Kassberg Thomas Richard
SEC CIK 1303811 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | EVP, CBO | 264.7K | — | $3.15M | 17 | 2021-09-30 | 2025-03-03 |
Most active insiders at RARE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Horn Howard | CFO | — | $1.33M |
| 2 | KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| 3 | Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| 4 | Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| 5 | Pinion John Richard | See Remarks | — | $228.7K |
| 6 | Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| 7 | SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| 8 | Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| 9 | Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| 10 | Ray Amrit | Dir | — | — |
Kassberg Thomas Richard made no open-market trades at RARE in the last 12 months.
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2025-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | F - Tax | $42.92 | -508 | 264.7K | -0.2% | -$21.8K | |
| 2025-03-04 | 2025-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | A - Grant | $0.00 | +18.4K | 271.3K | +7% | $0 | |
| 2025-03-04 | 2025-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | S - Sale | $42.10 | -6,028 | 265.2K | -2% | -$253.8K | |
| 2024-03-12 | 2024-03-11 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | S - Sale | $49.93 | -11.5K | 252.8K | -4% | -$574.6K | |
| DM | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | A - Grant | $0.00 | +18.8K | 265.6K | +8% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | S - Sale | $53.76 | -1,011 | 264.3K | -0.4% | -$54.4K |
| D | 2024-03-05 | 2024-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | F - Tax | $53.69 | -274 | 265.3K | -0.1% | -$14.7K |
| D | 2023-10-24 | 2023-10-23 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | S - Sale+OE | $32.78 | -39.9K | 246.9K | -14% | -$1.31M |
| D | 2023-10-24 | 2023-10-23 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | M - OptEx | $6.86 | +39.9K | 286.7K | +16% | +$273.6K |
| DM | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | A - Grant | $0.00 | +24.7K | 252.2K | +11% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | D - Sale to Iss | $45.65 | -3,394 | 246.9K | -1% | -$154.9K |
| D | 2023-03-03 | 2023-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | S - Sale | $45.27 | -1,968 | 250.3K | -0.8% | -$89.1K |
| 2022-03-15 | 2022-03-11 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | S - Sale | $67.01 | -10.3K | 227.6K | -4% | -$688.9K | |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | S - Sale | $66.62 | -2,374 | 213.8K | -1% | -$158.2K |
| D | 2022-03-03 | 2022-03-01 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | A - Grant | $0.00 | +14.0K | 227.8K | +7% | $0 |
| 2021-10-18 | 2021-10-14 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | S - Sale | $81.14 | -286 | 216.3K | -0.1% | -$23.2K | |
| D | 2021-10-01 | 2021-09-30 | RARE | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas Richard | EVP, CBO | M - OptEx | $0.31 | +109.7K | 216.6K | +103% | +$34.0K |
Purchase Sale Sale after option exercise All abbreviations